|
|
 |
|
Viewing report
|
|
|
|
Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi
Business Insights, April 2005, Pages: 186
- Aclara BioSciences
- Advion BioSciences, Inc.
- Agilent Technologies
- BioMicro Systems
- BioTrove Inc.
- Caliper Life Sciences
- Cepheid
- CombiMatrix Corp.
- Eksigent Technologies
- Epigem Limited
- Fluidigm Corp.
- Gyros AB
- Nanogen
- Nanostream Inc.
- Protiveris
- Sequenom
- Zyomyx
- 3DM Inc.
- Alnis Biosciences Inc.
- American Pharmaceuticals Partners Inc.
- BioCrystal Ltd.
- BioForce NanoSciences Inc.
- CrystalPlex Corp.
- C Sixty Inc.
- Evident Technologies, Inc.
- NanBio Corp.
- Nanosphere
- PharmaSeq, Inc
- Quantum Dot Corp.
- Ambion
- Alnylam Pharmaceuticals, Inc.
- Benitec Ltd
- CytRx Corp.
- Cenix BioScience
- Devgen
- Dharmacon, Inc.
- Eurogentec (EGT)
- Imgenex Corp.
- Immusol Inc.
- Invitrogen Corp.
- InvivoGen
- MWG Biotech
- Proligo
- Promega
- Qiagen.
- Sirna Therapeutics
Customers who bought this item also bought
RNAi - Technologies, Markets and Companies
RNAi 2008
Advances in Lab-on-Chip and Microfluidics Technologies for Drug Discovery and Clinical Diagnostics
The Outlook For RNAi: Accelerating Drug Discovery and the Development of RNAi Therapeutics
Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics
Lab on a Chip (LOC) -- Advances in Microfluidics
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
Realizing the Promise of Therapeutic RNAi: Emerging Strategies for RNAi Delivery
RNA Interference for Drug R&D: Applications, Alliances, Companies and WW Market to 2011
The Role of Nanotechnology in European Drug Discovery
RNAi Therapeutics 2008 Market Report
Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities
|
|
|
|
